Cookie Consent by FreePrivacyPolicy.com
Datalog Logo
Free data on 57M+ companies
Home > England & Wales Companies > OPPILAN PHARMA LIMITED
Company Information for

OPPILAN PHARMA LIMITED

5 NEW STREET SQUARE, LONDON, EC4A 3TW,
Company Registration Number
09610773
Private Limited Company
Active

Company Overview

About Oppilan Pharma Ltd
OPPILAN PHARMA LIMITED was founded on 2015-05-27 and has its registered office in London. The organisation's status is listed as "Active". Oppilan Pharma Limited is a Private Limited Company registered in UNITED KINGDOM with Companies House and the accounts submission requirement is categorised as TOTAL EXEMPTION FULL
  • Company qualifies as a small company
  • Company has filed full accounts
  • Company is exempt from audit
  • Annual turnover is less than £6.5 million
  • The balance sheet total is less than £ 3.26 million
  • Employs less than 50 employees
Key Data
Company Name
OPPILAN PHARMA LIMITED
 
Legal Registered Office
5 NEW STREET SQUARE
LONDON
EC4A 3TW
 
Filing Information
Company Number 09610773
Company ID Number 09610773
Date formed 2015-05-27
Country UNITED KINGDOM
Origin Country United Kingdom
Type Private Limited Company
CompanyStatus Active
Lastest accounts 31/05/2023
Account next due 31/12/2024
Latest return 27/05/2016
Return next due 24/06/2017
Type of accounts TOTAL EXEMPTION FULL
VAT Number /Sales tax ID GB292983451  
Last Datalog update: 2024-09-08 16:47:57
Primary Source:Companies House
Is this data useful to you?
If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.

Company Officers of OPPILAN PHARMA LIMITED

Current Directors
Officer Role Date Appointed
JASON HONG
Director 2016-12-16
CHRISTOPHER W. KRUEGER
Director 2016-12-20
RAJU MOHAN
Director 2015-05-27
NORMAN SELBY
Director 2016-05-01
SOMASUNDARAM SUBRAMANIAM
Director 2015-05-27
Previous Officers
Officer Role Date Appointed Date Resigned
OAKWOOD CORPORATE SECRETARY LIMITED
Company Secretary 2015-05-27 2017-05-17

Related Directorships

Officer Related Company Role Date Appointed Role StatusIncorporation dateCompany Status
SOMASUNDARAM SUBRAMANIAM ESCALIER BIOSCIENCES LIMITED Director 2016-05-06 CURRENT 2016-05-06 Dissolved 2017-01-31
SOMASUNDARAM SUBRAMANIAM BIOMODAL LIMITED Director 2014-08-02 CURRENT 2012-03-26 Active

More director information

Corporation Filing History
Companies House Filing History
This is a record of the public documents (corporate filing) lodged from Companies House where the company has filed annual returns and other statutory filing documents. Examples of documents filed include: change of registered office, accounts filing, director/officer appointments & resignations, changes in share capital, shareholder members lists etc.

DateDocument TypeDocument Description
2024-07-16Previous accounting period shortened from 31/05/24 TO 31/12/23
2024-06-18CESSATION OF SOMASUNDARAM SUBRAMANIAM AS A PERSON OF SIGNIFICANT CONTROL
2024-06-18Notification of a person with significant control statement
2024-06-18CONFIRMATION STATEMENT MADE ON 27/05/24, WITH NO UPDATES
2024-05-08APPOINTMENT TERMINATED, DIRECTOR CHRISTOPHER W. KRUEGER
2024-05-08DIRECTOR APPOINTED JOHN NUSS
2024-03-0731/05/23 ACCOUNTS TOTAL EXEMPTION FULL
2023-06-07CONFIRMATION STATEMENT MADE ON 27/05/23, WITH NO UPDATES
2023-03-0331/05/22 ACCOUNTS TOTAL EXEMPTION FULL
2022-06-01AA31/05/21 ACCOUNTS TOTAL EXEMPTION FULL
2022-05-27CS01CONFIRMATION STATEMENT MADE ON 27/05/22, WITH NO UPDATES
2021-07-08TM01APPOINTMENT TERMINATED, DIRECTOR JASON HONG
2021-06-21CS01CONFIRMATION STATEMENT MADE ON 27/05/21, WITH UPDATES
2021-05-11SH03Purchase of own shares
2021-04-02SH06Cancellation of shares. Statement of capital on 2021-02-26 USD 26,276.158
2021-03-30RES09Resolution of authority to purchase a number of shares
2021-03-30SH08Change of share class name or designation
2021-03-18TM01APPOINTMENT TERMINATED, DIRECTOR JIGAR CHOKSEY
2021-03-18AP01DIRECTOR APPOINTED JIGAR CHOKSEY
2021-03-17TM01APPOINTMENT TERMINATED, DIRECTOR NORMAN SELBY
2021-02-21SH08Change of share class name or designation
2020-11-30AP04Appointment of Taylor Wessing Secretaries Limited as company secretary on 2020-09-01
2020-11-30AD01REGISTERED OFFICE CHANGED ON 30/11/20 FROM St. Johns Innovation Centre Cowley Road Cambridge Cambridgeshire CB4 0WS
2020-10-15AA31/05/20 ACCOUNTS TOTAL EXEMPTION FULL
2020-07-24CS01CONFIRMATION STATEMENT MADE ON 27/05/20, WITH UPDATES
2020-07-24SH0119/08/19 STATEMENT OF CAPITAL USD 26318.033
2020-03-18AA31/05/19 ACCOUNTS TOTAL EXEMPTION FULL
2020-02-06SH0117/04/19 STATEMENT OF CAPITAL USD 26305.627
2020-02-03SH10Particulars of variation of rights attached to shares
2020-02-03SH08Change of share class name or designation
2020-02-03RES11Resolutions passed:
  • Resolution of removal of pre-emption rights
  • Resolution of varying share rights or name
  • Resolution of allotment of securities
2020-02-03RES12Resolution of varying share rights or name
2019-07-15CS01CONFIRMATION STATEMENT MADE ON 27/05/19, WITH UPDATES
2019-04-08SH0105/12/18 STATEMENT OF CAPITAL USD 17305.627
2019-04-08SH08Change of share class name or designation
2019-04-05RP04CS01Second filing of Confirmation Statement dated 27/05/2018
2019-01-04AA31/05/18 ACCOUNTS TOTAL EXEMPTION FULL
2018-06-08CS01CONFIRMATION STATEMENT MADE ON 27/05/18, WITH NO UPDATES
2018-03-06AA31/05/17 ACCOUNTS TOTAL EXEMPTION FULL
2018-02-26RP04CS01Second filing of Confirmation Statement dated 27/05/2017
2017-07-31PSC07CESSATION OF RAJU MOHAN AS A PERSON OF SIGNIFICANT CONTROL
2017-07-31PSC09Withdrawal of a person with significant control statement on 2017-07-31
2017-07-31PSC01NOTIFICATION OF A PERSON WITH SIGNIFICANT CONTROL SOMASUNDARAM SUBRAMANIAM
2017-07-31PSC01NOTIFICATION OF A PERSON WITH SIGNIFICANT CONTROL RAJU MOHAN
2017-06-09LATEST SOC09/06/17 STATEMENT OF CAPITAL;USD 17287.016
2017-06-09CS01CONFIRMATION STATEMENT MADE ON 27/05/17, WITH UPDATES
2017-06-09CS01CONFIRMATION STATEMENT MADE ON 27/05/17, WITH UPDATES
2017-06-07TM02Termination of appointment of Oakwood Corporate Secretary Limited on 2017-05-17
2017-05-31AP01DIRECTOR APPOINTED JASON HONG
2017-05-22SH0126/04/17 STATEMENT OF CAPITAL USD 17287.020
2017-04-11AD01REGISTERED OFFICE CHANGED ON 11/04/17 FROM 3rd Floor 1 Ashley Road Altrincham Cheshire WA14 2DT United Kingdom
2017-04-11AP01DIRECTOR APPOINTED CHRISTOPHER W. KRUEGER
2017-03-06AA31/05/16 ACCOUNTS TOTAL EXEMPTION SMALL
2017-01-19RES01ADOPT ARTICLES 19/01/17
2017-01-19SH0116/12/16 STATEMENT OF CAPITAL USD 13537.02
2017-01-18SH0105/12/16 STATEMENT OF CAPITAL USD 4537.02
2017-01-17RES11Resolutions passed:
  • Resolution of removal of pre-emption rights
  • Resolution of adoption of Articles of Association
2017-01-17RES01ADOPT ARTICLES 05/12/2016
2017-01-09AP01DIRECTOR APPOINTED NORMAN SELBY
2016-05-31LATEST SOC31/05/16 STATEMENT OF CAPITAL;USD 100
2016-05-31AR0127/05/16 ANNUAL RETURN FULL LIST
2015-05-27MODEL ARTICLESMODEL ARTICLES ADOPTED: PRIVATE LIMITED BY SHARES (AMENDED PROVISIONS)
2015-05-27NEWINCCERTIFICATE OF INCORPORATION GENERAL COMPANY DETAILS & STATEMENTS OF; OFFICERS, CAPITAL & SHAREHOLDINGS, GUARANTEE, COMPLIANCE MEMORANDUM OF ASSOCIATION ARTICLES OF ASSOCIATION
Industry Information
SIC/NAIC Codes
72 - Scientific research and development
721 - Research and experimental development on natural sciences and engineering
72110 - Research and experimental development on biotechnology




Licences & Regulatory approval
We could not find any licences issued to OPPILAN PHARMA LIMITED or authorisation from an industry specific regulator to operate. These may not be required.
Share this page on Facebook
Risks
Legal Notices
No legal notices or events such as winding-up orders or proposals to strike-off have been issued
Fines / Sanctions
No fines or sanctions have been issued against OPPILAN PHARMA LIMITED
Liabilities
Mortgages / Charges
Total # Mortgages/Charges 0
Mortgages/Charges outstanding 0
Mortgages Partially Satisifed 0
Mortgages Satisfied/Paid 0
Details of Mortgagee Charges
OPPILAN PHARMA LIMITED does not have any mortgage charges so there is no mortgagee data available

  Average Max

This shows the max and average number of mortgages for companies with the same SIC code of 72110 - Research and experimental development on biotechnology

Filed Financial Reports
Annual Accounts
2020-05-31

These are the financial reports (either an abhreviated set of accounts or profit& loss statement and balance sheet) have been filed with Companies House. The reports allow you to do a basic business credit check on OPPILAN PHARMA LIMITED

Intangible Assets
Patents
We have not found any records of OPPILAN PHARMA LIMITED registering or being granted any patents
Domain Names
We do not have the domain name information for OPPILAN PHARMA LIMITED
Trademarks
We have not found any records of OPPILAN PHARMA LIMITED registering or being granted any trademarks
Income
Government Income
We have not found government income sources for OPPILAN PHARMA LIMITED. This could be because the transaction value was below £ 500 with local government or below £ 25,000 for central government. We have found 8,000 supplier to government that are UK companies so approx 0.2% of companies listed on Datalog supply to government.

The top companies supplying to UK government with the same SIC code (72110 - Research and experimental development on biotechnology) as OPPILAN PHARMA LIMITED are:

Outgoings
Business Rates/Property Tax
No properties were found where OPPILAN PHARMA LIMITED is liable for the business rates / property tax. This could be for a number of reasons.
  • The council hasnt published the data
  • We havent found or been able to process the councils data
  • The company is part of a group of companies and another company in the group is liable for business rates
  • The registered office may be a residential address which does not have a commercial designation. If the business is run from home then it won't be a commercial property and hence won't be liable for business rates.
  • Serviced offices are increasingly popular and therefore a business may not be paying business rates directly - the building owner is and this is incorporated in the office rental charge.
Government Grants / Awards
Technology Strategy Board Awards
The Technology Strategy Board has not awarded OPPILAN PHARMA LIMITED any grants or awards. Grants from the TSB are an indicator that the company is investing in new technologies or IPR
European Union CORDIS Awards
The European Union has not awarded OPPILAN PHARMA LIMITED any grants or awards.
Ownership
    We could not find any group structure information
    Is this data useful to you?
    If you found the data here useful, PLEASE HELP US. We are a start-up and believe in making information freely available. Please DONATE to help.
    Alternatively by linking to us, posting on twitter, facebook and linkedin about us and generally spreading the word, you'll help us to grow. Our vision is to provide high quality data about the activities of all the companies in the world and where possible make it free to use and view. Finding and integrating data from thousands of data sources is time consuming and needs lots of effort. By simply spreading the word about us, you will help us.
    Need more information?
    We offer bespoke investigations into companies. If you need more information about this company we can gather more information as directed by you. This may, for example, be a forensic investigation such as tracing hidden assets. The engagement is on a time and materials basis. We charge GBP £ 500 per day + VAT. Contact us with a description of what you're looking for and we will assess whether we can help.